Form 4 for RARE Ultragenyx Pharmaceutical Inc.
Accepted 2021-10-18 00:00:00 ET · period of report 2021-10-14 · accession 0001209191-21-060765 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-18 | 2021-10-14 | RARE | Bedrosian Camille L | EVP, Chief Medical Off | S - Sale | $81.14 | -359 | 38.4K | -0.9% | -$29.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-14 | S | D | 359 | $81.14 | 38,416 | D | — | — | (F2) Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. |